Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma
- 25 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular Oncology
- Vol. 36 (6), 469-483
- https://doi.org/10.1007/s13402-013-0151-7
Abstract
Purpose SOX18 is a transcription factor known to be involved in hair follicle, blood and lymphatic vessel development, as well as wound healing processes (together with SOX7 and SOX17). In addition, it has been reported that SOX18 may affect the growth of cancer cells in vitro. Until now, the exact role of SOX18 expression in invasive ductal breast carcinoma (IDC) has remained unknown. Methods In this study, we have investigated SOX18 expression in cancer cells and endothelial cells in 122 IDC samples using immunohistochemistry (IHC). SOX18 expression was also determined using real-time PCR and Western blotting in a series of breast cancer-derived cell lines (i.e., MCF-7, BT-474, SK-BR-3, MDA-MB-231, BO2). Results Using IHC, we observed SOX18 nuclear expression in cancer cells, as well as in blood and lymphatic vessels of the IDC samples tested. SOX18 expression in the IDC samples correlated with a higher malignancy grade (Grade 2 and Grade 3 versus Grade 1; p = 0.02 and p = 0.009, respectively) and VEGF-D expression (r = 0.27, p = 0.007). SOX18 expression was also associated with HER2 positivity (p = 0.02). A significantly higher SOX18 expression was found in the HER2-positive cell line BT-474, and a significantly lower expression in the triple negative cell lines MDA-MB-231 and BO2. Laser capture microdissection of IDC samples revealed significantly higher mRNA SOX7, SOX17 and SOX18 expression levels in the vessels as compared to the cancer cells (p = 0.02 and p = 0.0002, p < 0.0001, respectively). SOX18 positive intratumoral and peritumoral microvessel counts (MVC) were associated with higher malignancy grades (p = 0.04 and p = 0.02, respectively). Moreover, peritumoral SOX18 positive MVC were found to act as an independent marker for a poor prognosis (p = 0.04). Conclusion SOX18 expression may serve as a marker for a poor prognosis in IDC.Keywords
This publication has 49 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastasesBritish Journal of Cancer, 2010
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene DiscoveryPLOS ONE, 2009
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals Of Oncology, 2009
- Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancerBreast Cancer Research and Treatment, 2009
- VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sitesBlood, 2006
- CpG island methylation and expression of tumour-associated genes in lung carcinomaEuropean Journal of Cancer, 2005
- Mutations in the Transcription Factor Gene SOX18 Underlie Recessive and Dominant Forms of Hypotrichosis-Lymphedema-TelangiectasiaAmerican Journal of Human Genetics, 2003
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal of Cancer, 2002
- Sequence and expression of Sox-18 encoding a new HMG-box transcription factorGene, 1995